DE2752694A1 - Verfahren zur gewinnung von immunglobulin zur intravenoesen verabreichung - Google Patents

Verfahren zur gewinnung von immunglobulin zur intravenoesen verabreichung

Info

Publication number
DE2752694A1
DE2752694A1 DE19772752694 DE2752694A DE2752694A1 DE 2752694 A1 DE2752694 A1 DE 2752694A1 DE 19772752694 DE19772752694 DE 19772752694 DE 2752694 A DE2752694 A DE 2752694A DE 2752694 A1 DE2752694 A1 DE 2752694A1
Authority
DE
Germany
Prior art keywords
plasmin
immunoglobulin
plasminogen
solution
lysine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
DE19772752694
Other languages
German (de)
English (en)
Inventor
Cyrill John Campbell
Daniel Ting Hsiu Liu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Oesterreichisches Institut fuer Haemoderivate
Original Assignee
Parke Davis and Co LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Parke Davis and Co LLC filed Critical Parke Davis and Co LLC
Publication of DE2752694A1 publication Critical patent/DE2752694A1/de
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/06—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies from serum
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/829—Blood
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/829—Blood
    • Y10S530/83—Plasma; serum
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/829—Blood
    • Y10S530/83—Plasma; serum
    • Y10S530/831—Cohn fractions

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE19772752694 1976-11-26 1977-11-25 Verfahren zur gewinnung von immunglobulin zur intravenoesen verabreichung Withdrawn DE2752694A1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/744,906 US4075193A (en) 1976-11-26 1976-11-26 Process for producing intravenous immune globulin

Publications (1)

Publication Number Publication Date
DE2752694A1 true DE2752694A1 (de) 1978-06-01

Family

ID=24994418

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19772752694 Withdrawn DE2752694A1 (de) 1976-11-26 1977-11-25 Verfahren zur gewinnung von immunglobulin zur intravenoesen verabreichung

Country Status (7)

Country Link
US (1) US4075193A (cg-RX-API-DMAC7.html)
JP (1) JPS5369823A (cg-RX-API-DMAC7.html)
CA (1) CA1083959A (cg-RX-API-DMAC7.html)
DE (1) DE2752694A1 (cg-RX-API-DMAC7.html)
FR (1) FR2372173B1 (cg-RX-API-DMAC7.html)
GB (1) GB1552708A (cg-RX-API-DMAC7.html)
NL (1) NL7713023A (cg-RX-API-DMAC7.html)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2846412A1 (de) * 1978-10-25 1980-05-08 Behringwerke Ag Mittel zur behandlung allergischer reaktionen
DE4344824C1 (de) * 1993-12-28 1995-08-31 Immuno Ag Hochkonzentriertes Immunglobulin-Präparat und Verfahren zu seiner Herstellung

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK139056B (da) * 1976-04-06 1978-12-11 Nordisk Insulinlab Fremgangsmåde til udvinding af immunoglobulin, der er egnet til intravenøs indgivelse.
US4164495A (en) * 1976-04-06 1979-08-14 Nordisk Insulinlaboratorium Method of recovering immunoglobulin using a polyol and an alkanoic acid
DE2658334C3 (de) * 1976-12-23 1987-05-07 Behringwerke Ag, 3550 Marburg Verfahren zum Herstellen von Immunglobulinpräparationen mit verminderter Komplementaktivität und ein diese enthaltendes Arzneimittel
US4296027A (en) * 1977-08-31 1981-10-20 The Regents Of The University Of Minnesota Pure intravenous human and animal gamma globulins
JPS55124719A (en) * 1979-03-22 1980-09-26 Kowa Co Preparation of immune globulin administrable by intravenous injection
US4272521A (en) * 1979-07-16 1981-06-09 Cutter Laboratories, Inc. Purified immune serum globulin
DE2933015A1 (de) * 1979-08-16 1981-03-26 Behringwerke AG, 35041 Marburg Verfahren zur herstellung der dritten komponente des komplements aus menschlichem blutplasma
JPH0662436B2 (ja) * 1986-05-19 1994-08-17 株式会社ミドリ十字 静注用免疫グロブリン製剤の製造方法
US5219578A (en) * 1991-02-25 1993-06-15 Innovet, Inc. Composition and method for immunostimulation in mammals
US5211850A (en) * 1991-07-26 1993-05-18 Research Medical, Inc. Plasma filter sorbent system for removal of components from blood
EP0835880A1 (de) * 1996-10-14 1998-04-15 Rotkreuzstiftung Zentrallaboratorium Blutspendedienst Srk Verfahren zur Herstellung eines IgM Präparates für die intravenöse Applikation
US20020077276A1 (en) * 1999-04-27 2002-06-20 Fredeking Terry M. Compositions and methods for treating hemorrhagic virus infections and other disorders
DE60139944D1 (de) * 2000-10-12 2009-10-29 Genentech Inc Niederviskose konzentrierte proteinformulierungen
US8703126B2 (en) 2000-10-12 2014-04-22 Genentech, Inc. Reduced-viscosity concentrated protein formulations
US20100184132A1 (en) * 2006-01-13 2010-07-22 Secretary, Department Of Atomic Energy Enzymatic Process for Debittering of Protein Hydrolysate Using Immobilized Peptidases
EP2237804B1 (en) * 2007-12-21 2013-04-10 GE Healthcare Bio-Sciences AB Method for sterilization of chemically activated solid support materials
PE20120359A1 (es) * 2009-03-06 2012-04-13 Genentech Inc Formulacion con anticuerpo
PT2542257T (pt) 2010-03-01 2017-10-09 Bayer Healthcare Llc Anticorpos monoclonais otimizados contra inibidor da via do fator tecidual (tfpi)
US8613919B1 (en) 2012-08-31 2013-12-24 Bayer Healthcare, Llc High concentration antibody and protein formulations
US9592297B2 (en) 2012-08-31 2017-03-14 Bayer Healthcare Llc Antibody and protein formulations
US20180305401A1 (en) * 2015-10-21 2018-10-25 Cambryn Biologics, Llc Processes for purifying proteins from plasma
CN121135917B (zh) * 2025-11-17 2026-02-24 南昌大学第一附属医院 Nhs活化的赖氨酸-琼脂糖凝胶微球及其制备方法和应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3966906A (en) * 1961-10-11 1976-06-29 Behringwerke Aktiengesellschaft Disaggregated gamma globulin and process for preparing it
US3449316A (en) * 1967-03-03 1969-06-10 American Cyanamid Co Process for the purification of gamma globulin employing bentonite
US3808124A (en) * 1972-04-14 1974-04-30 American Cyanamid Co Purification of human plasminogen
US3943245A (en) * 1974-02-14 1976-03-09 Armour Pharmaceutical Company Purification of plasminogen

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2846412A1 (de) * 1978-10-25 1980-05-08 Behringwerke Ag Mittel zur behandlung allergischer reaktionen
EP0010309A3 (en) * 1978-10-25 1980-06-25 Behringwerke Aktiengesellschaft Agent for treating allergic reactions and application thereof
DE4344824C1 (de) * 1993-12-28 1995-08-31 Immuno Ag Hochkonzentriertes Immunglobulin-Präparat und Verfahren zu seiner Herstellung

Also Published As

Publication number Publication date
FR2372173A1 (cg-RX-API-DMAC7.html) 1978-06-23
NL7713023A (nl) 1978-05-30
CA1083959A (en) 1980-08-19
GB1552708A (en) 1979-09-19
FR2372173B1 (cg-RX-API-DMAC7.html) 1981-01-09
US4075193A (en) 1978-02-21
JPS5369823A (en) 1978-06-21

Similar Documents

Publication Publication Date Title
DE2801123C2 (de) Verfahren zur Herstellung eines intravenös applizierbaren Serumeiweiß-Präparates
DE2630753C2 (cg-RX-API-DMAC7.html)
DE69002427T2 (de) Verfahren zur Herstellung eines Konzentrats des Faktor VIII-von Willebrand-Faktor-Komplexes der Blutgerinnung aus Vollplasma.
DE69017050T2 (de) Verfahren zur isolierung von faktor viii.
DE19531637A1 (de) Pharmazeutische Zusammensetzung zur Behandlung von Blutgerinnungsstörugnen, Verfahren zur Herstellung derselben und deren Verwendung
DE2429191A1 (de) Isolierung von koagulationsfaktoren aus biologischem material
DE3786832T2 (de) Verfahren zur Herstellung von Immunoglobulinzubereitungen für intravenöse Injektion.
CH646061A5 (de) Blutgerinnungsfoerdernde praeparation auf basis von humanproteinen sowie verfahren zu ihrer herstellung.
DE2459291B2 (de) Verfahren zur Herstellung eines antihämophiles Globulin A enthaltenden Konzentrats neben einem Prothrom-bin-Komplex und einer Lösung von lagerstabilen Serumproteinen
EP0307002B1 (de) Verfahren zur Herstellung eines Antithrombin III-Konzentrates
DE2459915C3 (de) Aktive Verbindung des Plasminogen- Typs, Verfahren zu ihrer Reinigung und ihre Verwendung
DE3229132A1 (de) Reinigung von rinder-thrombin
DE2323981C3 (de) Verfahren zur Isolierung des thrombinartig wirkenden Bestandteils aus dem Gift der Otter Agkistrodon rhodostoma
EP0139975A1 (de) Verfahren zur Pasteurisierung von Humanplasma
DE3152621C2 (cg-RX-API-DMAC7.html)
EP0120835B1 (de) Verfahren zur Inaktivierung von Unverträglichkeitsreaktionen verursachenden Substanzen
DE2605576C3 (de) Verfahren zum Isolieren der Proteasen Papain,,Chimopapain, Lysozym und Proteinase X aus dem Milchsaft von Carica papya und Verwendung der isolierten Proteasen zur Herstellung von sterilisierten und Iyophilisirten orthopädischen, neurochirurgischen oder ophthalmologischen Präparaten
DE3306944C2 (cg-RX-API-DMAC7.html)
DE1442134B2 (de) In vivo antikoagulierend wirkendes und defibrinierendes Enzym
DE2428955C3 (de) Verfahren zur Abtrennung der enzymatischen Komponente mit in vivo antikoagulierender und in vitro koagulierender Wirkung aus dem Gift der Schlange Ancistrodon rhodostoma und daraus hergestellte Mittel
DE2515666C3 (de) Piasminreiche Gammaglobulinfraktion, Verfahren zu deren Herstellung und das Verfahrensprodukt enthaltendes Gammaglobulinpräparat
DE3410694C2 (cg-RX-API-DMAC7.html)
EP0549964A2 (de) Verfahren zur Herstellung eines virusinaktivierten Prothrombin-komplex-Konzentrats (PPSB)
DE1617279A1 (de) Verfahren zur Herstellung pharmazeutischer Praeparate zur Verhinderung der Bildung von Blutgerinnseln
DE2533183C3 (de) Verfahren zum Herstellen gereinigter Immunglobuline

Legal Events

Date Code Title Description
8127 New person/name/address of the applicant

Owner name: IMMUNO AKTIENGESELLSCHAFT FUER CHEMISCH-MEDIZINISC

8141 Disposal/no request for examination